Renal Cancer
Chronic Oxidative Stress Increases Resistance to Doxorubicin-Induced Cytotoxicity in Renal Carcinoma Cells Potentially Through Epigenetic Mechanism
November 3, 2015
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
November 3, 2015
Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting
October 29, 2015
Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients
October 28, 2015
Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)
October 28, 2015
Preclinical evidence that trametinib enhances the response to anti-angiogenic tyrosine kinase inhibitors in renal cell carcinoma
October 27, 2015
Genomic characterisation of two cancers of unknown primary cases supports a kidney cancer origin
October 26, 2015
The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
October 21, 2015
IL-37 mediates the antitumor activity in renal cell carcinoma
October 21, 2015
Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status
October 21, 2015
[A pilot study of sunitinib as first-line therapy for metastatic renal cell carcinoma on a 2 weeks on/1 week off intermittent dosing schedule]
October 21, 2015